Cargando…
COVID-19 vaccination in people with multiple sclerosis, real-life experience
BACKGROUND: Vaccination against the severe acute respiratory syndrome coronavirus type-2 (SARS-CoV-2) virus is recommended in multiple sclerosis (MS) to reduce the risk of complications from Coronavirus disease 2019 (COVID-19) infection. These vaccines were not investigated in people with MS (PWMS)....
Autores principales: | Alroughani, Raed, Al-Hashel, Jasem, Abokalawa, Fathi, AlMojel, Malak, Farouk Ahmed, Samar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293951/ https://www.ncbi.nlm.nih.gov/pubmed/35961255 http://dx.doi.org/10.1016/j.clineuro.2022.107374 |
Ejemplares similares
-
COVID-19 Vaccination in People with Multiple Sclerosis. the Kuwait Experience
por: Alroughani, Raed, et al.
Publicado: (2022) -
COVID-19 and headache: Impact on pre-existing and characteristics of de novo: A cross-sectional study
por: Ahmed, Samar Farouk, et al.
Publicado: (2021) -
Effectiveness and Safety of Dimethyl Fumarate Treatment in Relapsing Multiple Sclerosis Patients: Real-World Evidence
por: Alroughani, Raed, et al.
Publicado: (2017) -
Coronavirus disease-19 and headache; impact on pre-existing and characteristics of de novo: a cross-sectional study
por: Al-Hashel, Jasem Youssef, et al.
Publicado: (2021) -
Association of Multiple Sclerosis and COVID-19 Infection: A Case Report
por: Ismail, Ismail Ibrahim, et al.
Publicado: (2022)